101 related articles for article (PubMed ID: 17328734)
1. Treatment of infections caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region.
Parkins MD; Pitout JDD; Church DL; Conly JM; Laupland KB
Clin Microbiol Infect; 2007 Feb; 13(2):199-202. PubMed ID: 17328734
[TBL] [Abstract][Full Text] [Related]
2. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.
Laupland KB; Parkins MD; Church DL; Gregson DB; Louie TJ; Conly JM; Elsayed S; Pitout JD
J Infect Dis; 2005 Nov; 192(9):1606-12. PubMed ID: 16206075
[TBL] [Abstract][Full Text] [Related]
3. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
4. Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.
Araoka H; Baba M; Takagi S; Matsuno N; Ishiwata K; Nakano N; Tsuji M; Yamamoto H; Seo S; Asano-Mori Y; Uchida N; Masuoka K; Wake A; Taniguchi S; Yoneyama A
Scand J Infect Dis; 2010 Mar; 42(3):231-3. PubMed ID: 20001223
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of metallo-beta-lactamase-mediated resistance challenging antimicrobial therapy against Pseudomonas aeruginosa in a Brazilian teaching hospital.
Zavascki AP; Goldani LZ; Gonçalves AL; Martins AF; Barth AL
Epidemiol Infect; 2007 Feb; 135(2):343-5. PubMed ID: 16824253
[TBL] [Abstract][Full Text] [Related]
6. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
[TBL] [Abstract][Full Text] [Related]
9. Metallo-β-lactamase-producing Pseudomonas aeruginosa in two Iranian teaching hospitals, their antimicrobial susceptibility and serotypes.
Yousefi S; Nahaei MR; Farajnia S; Akhi MT; Ghotaslou R; Lotfipour F; Soroush MH
J Chemother; 2011 Apr; 23(2):114-6. PubMed ID: 21571630
[No Abstract] [Full Text] [Related]
10. Biofilm and metallo beta-lactamase production among the strains of Pseudomonas aeruginosa and Acinetobacter spp. at a Tertiary Care Hospital in Kathmandu, Nepal.
Baniya B; Pant ND; Neupane S; Khatiwada S; Yadav UN; Bhandari N; Khadka R; Bhatta S; Chaudhary R
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):70. PubMed ID: 29096652
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa.
Yamada K; Yanagihara K; Kaku N; Harada Y; Migiyama Y; Nagaoka K; Morinaga Y; Nakamura S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Hasegawa H; Yasuoka A; Kohno S
Int J Antimicrob Agents; 2013 Sep; 42(3):238-43. PubMed ID: 23891525
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals.
Zavascki AP; Barth AL; Gaspareto PB; Gonçalves AL; Moro AL; Fernandes JF; Goldani LZ
J Antimicrob Chemother; 2006 Oct; 58(4):882-5. PubMed ID: 16895936
[TBL] [Abstract][Full Text] [Related]
13. Clusters of infection due to metallo-β-lactamase-producing Pseudomonas aeruginosa in stem cell transplant and haematology units.
Paez J; Levin AS; Fu L; Basso M; Fonseca GH; Dulley FL; Rossi F; Guimarães T; Costa SF
J Hosp Infect; 2011 Jan; 77(1):76-7. PubMed ID: 21030111
[No Abstract] [Full Text] [Related]
14. Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients.
Varaiya A; Kulkarni N; Kulkarni M; Bhalekar P; Dogra J
Indian J Med Res; 2008 Apr; 127(4):398-402. PubMed ID: 18577797
[TBL] [Abstract][Full Text] [Related]
15. Emergence of a New Delhi metallo-β-lactamase-1-producing Pseudomonas aeruginosa in Singapore.
Teo JW; La MV; Jureen R; Lin RT
Emerg Microbes Infect; 2015 Nov; 4(11):e72. PubMed ID: 26632659
[No Abstract] [Full Text] [Related]
16. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology and clinical implications of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from urine.
Sako S; Kariyama R; Mitsuhata R; Yamamoto M; Wada K; Ishii A; Uehara S; Kokeguchi S; Kusano N; Kumon H
Acta Med Okayama; 2014; 68(2):89-99. PubMed ID: 24743784
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial Infections with IMP-19-Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France.
Amoureux L; Riedweg K; Chapuis A; Bador J; Siebor E; Péchinot A; Chrétien ML; de Curraize C; Neuwirth C
Emerg Infect Dis; 2017 Feb; 23(2):304-307. PubMed ID: 28098548
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study.
Zavascki AP; Barth AL; Fernandes JF; Moro AL; Gonçalves AL; Goldani LZ
Crit Care; 2006; 10(4):R114. PubMed ID: 16882337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
